Scholarly Index

Anil K. Sood

The University of Texas MD Anderson Cancer Center; 170,170 total citations; 2,286 total publications; best world rank #1

The University of Texas MD Anderson Cancer Center

170,170Total citations
2,286Total publications
173H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Medical and Health SciencesLifetime285US 15599.99
Biological SciencesLifetime839US 45799.90
Molecular BiologyLifetime498US 31199.76
Reproductive MedicineLifetime61US 2699.66
Cancer ResearchLifetime92US 5499.51
OncologyLifetime217US 11899.66
Pulmonary and Respiratory MedicineLifetime349US 19199.57
Materials ChemistryLifetime849US 23799.08
Medical PhysiologyLifetime822US 42198.47
Psychiatry and Mental healthLifetime522US 26498.18
Obstetrics and GynecologyLifetime349US 15897.51
Pulmonary and Respiratory Medicine2021-2025310US 9797.09
Reproductive Medicine2021-2025121US 3595.16
Surgery2021-2025628US 24094.58
Oncology2021-2025491US 21693.55
Cancer Research2021-2025423US 16868.23
Ovarian cancer diagnosis and treatmentLifetime3US 299.92
Cancer, Stress, Anesthesia, and Immune ResponseLifetime1US 199.94
MicroRNA in disease regulationLifetime29US 1799.79
Cancer-related molecular mechanisms researchLifetime88US 3499.49
Angiogenesis and VEGF in CancerLifetime33US 1699.68
Endometrial and Cervical Cancer TreatmentsLifetime66US 3899.50
RNA Interference and Gene DeliveryLifetime204US 10499.32
Cancer Genomics and DiagnosticsLifetime236US 15199.50
Chronic Obstructive Pulmonary Disease (COPD) ResearchLifetime178US 6399.24
Inflammatory Biomarkers in Disease PrognosisLifetime57US 1797.97
Cancer Mechanisms and TherapyLifetime97US 5298.83
Intraperitoneal and Appendiceal MalignanciesLifetime67US 3398.99
Cancer, Hypoxia, and MetabolismLifetime477US 22898.67
Cancer Cells and MetastasisLifetime299US 14198.62
Carbon Nanotubes in CompositesLifetime267US 8898.70
Circular RNAs in diseasesLifetime278US 5998.12
Cancer, Lipids, and MetabolismLifetime368US 19198.53
Asthma and respiratory diseasesLifetime590US 21798.65
PARP inhibition in cancer therapyLifetime183US 9497.42
Endometriosis Research and TreatmentLifetime357US 11397.94
Plant tissue culture and regenerationLifetime583US 17097.71
Prostate Cancer Treatment and ResearchLifetime701US 37798.07
Cancer survivorship and careLifetime432US 21597.31
Cancer-related Molecular PathwaysLifetime742US 38897.59
Prostate Cancer Diagnosis and TreatmentLifetime603US 29398.13
Renal cell carcinoma treatmentLifetime641US 34097.46
Diamond and Carbon-based Materials ResearchLifetime907US 20696.91
Neuropeptides and Animal PhysiologyLifetime925US 40297.23
Bladder and Urothelial Cancer TreatmentsLifetime732US 32297.32
Adipokines, Inflammation, and Metabolic DiseasesLifetime809US 32296.81
Material Dynamics and PropertiesLifetime527US 20096.94
Nanopore and Nanochannel Transport StudiesLifetime409US 14995.42
Uterine Myomas and TreatmentsLifetime759US 24695.72
Cancer Risks and FactorsLifetime745US 38895.21
Urologic and reproductive health conditionsLifetime825US 40295.26
Pregnancy-related medical researchLifetime762US 27692.34
Bamboo properties and applicationsLifetime310US 2390.47
Axon Guidance and Neuronal SignalingLifetime861US 36889.98
Hippo pathway signaling and YAP/TAZLifetime832US 34588.13
Chemotherapy-related skin toxicityLifetime573US 26985.79
Ovarian cancer diagnosis and treatment2021-2025144US 4297.57
Prostate Cancer Diagnosis and Treatment2021-2025401US 11995.75
Prostate Cancer Treatment and Research2021-2025547US 20195.28
Urologic and reproductive health conditions2021-2025182US 4190.47
Intraperitoneal and Appendiceal Malignancies2021-2025190US 4290.26
Bladder and Urothelial Cancer Treatments2021-2025671US 19692.55
PARP inhibition in cancer therapy2021-2025535US 19686.01
Endometrial and Cervical Cancer Treatments2021-2025850US 18388.64
Urinary and Genital Oncology Studies2021-2025645US 20085.82
Cancer, Stress, Anesthesia, and Immune Response2021-2025573US 13866.46
Angiogenesis and VEGF in Cancer2021-2025780US 15759.15
Axon Guidance and Neuronal Signaling2021-2025477US 15545.12
Mentoring and Academic Development2021-2025412US 32442.38